The Gluten-Free Landscape: Consumer Demand Meets Regulatory Change

Gluten-free diets sit at the intersection of clinical necessity and consumer choice, with celiac disease affecting millions and voluntary gluten avoidance remaining a steady dietary pattern. As the FDA moves to tighten labeling requirements for gluten-containing grains and certification bodies and researchers advance product safety and nutrient density, manufacturers face both new compliance considerations and fresh formulation opportunities.

What Is Celiac Disease?

As the National Institute of Diabetes and Digestive and Kidney Diseases explains, celiac disease is a chronic autoimmune disorder in which ingesting gluten—a protein found in wheat, barley, and rye—triggers damage to the small intestine and can impair nutrient absorption.¹ An estimated 2 million people in the United States, and approximately 1% of people worldwide, have celiac disease.

What Health Risks Does Untreated Celiac Disease Carry?

If left unmanaged, celiac disease is associated with complications including osteoporosis, anemia, and malnutrition. The Celiac Disease Foundation highlights bone health as a particular concern: Osteoporosis is present in approximately 26% to 72% of individuals at the time of diagnosis, even among those without digestive symptoms.² Bone density scans are frequently recommended at diagnosis or after a year on a gluten-free diet.

Does a Gluten-Free Diet Reverse These Effects?

A strict gluten-free diet generally supports intestinal healing and restores nutrient absorption over time, though some individuals need targeted support to meet requirements for calcium, vitamin D, vitamin K, and magnesium. Nutrients considered especially important for individuals with celiac disease include calcium, vitamin D, iron, vitamin B₁₂, folic acid, and zinc.

How Many Americans Are Actually Following a Gluten-Free Diet?

Beyond diagnosed celiac disease, gluten-free eating also functions as a voluntary dietary pattern. The 2025 International Food Information Council Food and Health Survey found that 7% of US adults reported following a gluten-free diet in the past year—well behind more common patterns such as high protein (23%) and mindful eating (19%), but still a notable segment of consumers.³

What Regulatory Changes Are Shaping Gluten-Free Labeling?

In January 2026, the FDA issued a request for information seeking data on nonwheat gluten-containing grains such as rye and barley, as well as oats subject to cross-contact, as part of a broader push for increased transparency in packaged food labeling.⁴ The agency is gathering information on the prevalence of products that do not disclose rye or barley contents, the severity of allergic reactions to rye and barley, and concerns surrounding the gluten content of cross-contaminated oats. The inquiry follows a citizen petition arguing that gluten should be labeled as a major food allergen on all US packaged foods, because current rules require only wheat disclosure. Findings are expected to inform future labeling regulations intended to protect individuals with celiac disease.

How Is Product Development Addressing Nutrient Gaps?

Recent formulation research illustrates how researchers are working to close nutritional shortfalls common in gluten-free products. A study in Frontiers in Nutrition documented the development of gluten-free cereal bars using wild seeds, puffed rice, and plant-based binders, achieving approximately 18 g/100 g of protein and up to 29.2 g/100 g of fiber alongside strong sensory acceptance scores.⁵ Researchers also applied nonthermal cold plasma treatment, which reduced microbial loads by more than 70% while preserving bioactive compounds that thermal processing might degrade. Such approaches offer a possible model for pairing nutrient density with shelf-life stability in celiac-focused product lines.

What Does This Mean for Food Manufacturers?

Together, these developments point to a gluten-free category shaped by both regulatory scrutiny and formulation innovation. Manufacturers may benefit from monitoring the FDA’s labeling proceedings and exploring nutrient-dense, allergen-conscious formulations that address the specific deficiencies associated with celiac disease management.

References

1. Definition & facts for celiac disease. National Institute of Diabetes and Digestive and Kidney Diseases. Reviewed October 2020. Accessed July 26, 2026. https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease/definition-facts
2. World Osteoporosis Day: celiac disease and bone health. Celiac Disease Foundation. October 16, 2025. Accessed July 26, 2026. https://celiac.org/2025/10/16/world-osteoporosis-day-celiac-disease-and-bone-health/
3. 2025 IFIC Food & Health Survey: The Full Report. International Food Information Council; 2026. Accessed July 26, 2026. https://ific.org/wp-content/uploads/2025-IFIC-Food-Health-Survey-Full-Report.pdf
4. McEvoy E. FDA issues request for information to shape future gluten labeling regulations. Nutritional Outlook. January 21, 2026. Accessed July 26, 2026. https://www.nutritionaloutlook.com/view/fda-issues-request-for-information-to-shape-future-gluten-labeling-regulations
5. Ferradji S, Bourekoua H, Djeghim F, et al. Development, optimization and microbial stability of innovative gluten-free cereal bars. Front Nutr. 2026;13:1820013. doi:10.3389/fnut.2026.1820013